LCC 2026 Funding Opportunity: Pharmacist Reviewers for ‘Let’s Communicate Cancer’ Programme

Let’s Communicate Cancer review 2026

The BOPA Education and Training Subcommittee have a great opportunity for pharmacists to become involved in the review of the ‘Let’s communicate cancer’ training modules. ‘Let’s communicate cancer’ is an extensive resource for all health professionals on many aspects of cancer care. The resource includes information on cancer prevention, diagnosis, treatments, and how to better support patients undergoing cancer treatment. There are five training modules:

  • Module 1: Early diagnosis and prevention
  • Module 2: What is cancer
  • Module 3: Treatment of cancer
  • Module 4: Supporting your patients with cancer
  • Module 5: A Patient Journey

Who are we looking for?   For the update, we are looking for a number of experienced pharmacists to review the eLearning content which includes powerpoint presentations, quizzes, PDFs and videos. If you have a minimum of 3 years’ experience practicing in oncology, or alternatively, if you are a community pharmacist with an interest in oncology we would love to hear from you.

How to apply?
   If you would like to get involved please complete a brief statement (roughly 300 words) of the skills and experience you have which would be beneficial in the review of the modules. Please also include your current role and place of work.

Applications should be sent via the MS Form. Please note, applications will close on 15th May 2026 and we will let candidates know the outcome by 5th June 2026.   Thank you!

We understand everyone is under increased pressure at the moment and the reviewer will be remunerated for their valuable time at a rate of £50/hour (capped at £250 per person). We aim to have the review completed by the end of September.  By completing the application form you are confirming agreement of the terms of review.

Thank you for considering this opportunity and we look forward to hearing from you!

Best wishes,

Jenny Allen LCC Lead

Latest News

By BOPA Executive Committee on 30th October 2026

Publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs

We are delighted to recognise the recent publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs, a new book bringing together expertise from oncology pharmacy professionals across the world.…

Read article
By BOPA Executive Committee on 30th October 2026

Acute and Supportive Oncology Clinical Consensus Statement

BOPA welcomes the Acute and Supportive Oncology Clinical Consensus Statement, to which we were pleased to contribute. It will be a benchmark for the sector, bringing direction and consistency as…

Read article
By BOPA, COSA, CAPhO & ISOPP on 13th October 2026

International Debate Webinar: Eastern and Western Medicine Can Co-exist – part of London Global Cancer Week 2026

Monday 2 November 2026 | 21:00 GMT (check your local time) Part of London Global Cancer Week 2026 Can Eastern and Western medicine co-exist in modern cancer care? Or do…

Read article
By Joseph Williams on 8th October 2026

BOPA 2026 Mentioned in Pharmaceutical Journal

Invest in aseptic services for future of specialised medicines, says chief pharmacist – The Pharmaceutical Journal Aseptic facilities are “absolutely essential” for hospitals to be involved in clinical trials and…

Read article